Duration of Response as Clinical Endpoint: A Quick Guide for Clinical Researchers

被引:0
|
作者
Kim, Seonok [1 ]
Kim, Min-Ju [1 ]
Choe, Jooae [2 ]
机构
[1] Asan Med Ctr, Dept Clin Epidemiol & Biostat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol,Dept Radiol, Seoul, South Korea
关键词
Survival analysis; Time-to-event analysis; Statistical method; Duration of response; Probability of being in response;
D O I
10.3348/kjr.2024.0589
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:937 / 941
页数:5
相关论文
共 50 条
  • [31] Endpoint considerations for clinical trials
    Walton, MK
    AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2002, 3 : S3 - S6
  • [32] NECESSITY OF CLINICAL RESEARCHERS
    HERNANDEZ, SV
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1986, 38 (03): : 329 - 330
  • [33] CLINICAL RESEARCHERS, BY THE BOOK
    CULLITON, BJ
    NATURE MEDICINE, 1995, 1 (10) : 990 - 990
  • [34] THE VARIATION IN CLINICAL-RESPONSE TO MARPLAN WITH DURATION OF ILLNESS
    SCHOPBACH, RR
    AMERICAN JOURNAL OF PSYCHIATRY, 1961, 117 (08): : 746 - 747
  • [35] Inferences for the distribution of the duration of response in a comparative clinical study
    Cui, Ying
    Huang, Bo
    Mao, Lu
    Uno, Hajime
    Wei, Lee-Jen
    Tian, Lu
    CLINICAL TRIALS, 2024, 21 (05) : 541 - 552
  • [36] Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
    Kimball, A. B.
    Jemec, G. B. E.
    Yang, M.
    Kageleiry, A.
    Signorovitch, J. E.
    Okun, M. M.
    Gu, Y.
    Wang, K.
    Mulani, P.
    Sundaram, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : 1434 - 1442
  • [37] Establishing and Using Threshold of Surrogate Endpoint in Relation to Clinical Endpoint
    Cheng, Yu-Chieh
    Tsou, Hsiao-Hui
    Hung, H. M. James
    Fan, Byron
    Fan, Brandon
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024,
  • [38] Latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint
    Hu, Chuanpu
    Szapary, Philippe O.
    Mendelsohn, Alan M.
    Zhou, Honghui
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (04) : 335 - 349
  • [39] From scientific discovery to clinical trial: Overcoming the regulatory hurdles - A guide for academic researchers
    Bennet, JK
    VACCINE DESIGN: THE ROLE OF CYTOKINE NETWORKS, 1997, 293 : 187 - 196
  • [40] Abbreviated PTSD Checklist (PCL) as a guide to clinical response
    Lang, Ariel J.
    Wilkins, Kendall
    Roy-Byrne, Peter P.
    Golinelli, Daniela
    Chavira, Denise
    Sherbourne, Cathy
    Rose, Raphael D.
    Bystritsky, Alexander
    Sullivan, Greer
    Craske, Michelle G.
    Stein, Murray B.
    GENERAL HOSPITAL PSYCHIATRY, 2012, 34 (04) : 332 - 338